Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II

Eur J Heart Fail. 2008 Feb;10(2):140-8. doi: 10.1016/j.ejheart.2007.12.012.


Aims: This analysis evaluates the gender differences in patients hospitalised for acute heart failure (AHF) in the EuroHeart Failure Survey II (EHFS).

Results: Of the 3580 patients included in EHFS II, 1384 (39%) were women, mean age 73 years. 2196 (61%) were men, mean age 68 years. Women more frequently had new-onset AHF, hypertension and valvular disease and less frequently coronary heart disease or dilated cardiomyopathy compared with men. Smoking, chronic obstructive pulmonary disease, peripheral arterial disease and renal failure were less common, but diabetes and anaemia significantly more frequent in women. Atrial fibrillation and preserved left ventricular function were more common in women. Men were more often non-compliant with medication. After adjustment for indications and age, there were no significant gender differences in prescription of HF medication. All-cause readmission rate during the one-year follow-up was lower in women. However, the proportion of HF hospitalisation and one-year mortality after discharge (20%) were similar in both genders.

Conclusion: Women frequently present with new-onset AHF. A significant gender difference exists in aetiology, ventricular function and co-morbidities. Women's use of HF medication has improved. These findings emphasize the importance of individualised management and need for more comprehensive recruitment of women in clinical trials.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / epidemiology
  • Comorbidity
  • Europe / epidemiology
  • Female
  • Health Surveys
  • Heart Failure / drug therapy
  • Heart Failure / epidemiology*
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Sex Factors
  • Stroke Volume
  • Ventricular Dysfunction / epidemiology